Aarti Drugs Ltd 524348
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹525.55
- Day Range
- ₹525.30–541.30
- 52-Week Range
- ₹430.00–624.00
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹48.40 Bil
- Volume/Avg
- 2,992 / 12,913
Key Statistics
- Price/Earnings (Normalized)
- 31.08
- Price/Sales
- 2.00
- Dividend Yield (Trailing)
- 0.19%
- Dividend Yield (Forward)
- 0.19%
- Total Yield
- 1.43%
Company Profile
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,590
- Website
- https://www.aartidrugs.co.in
Comparables
Valuation
|
Metric
|
524348
|
543434
|
543748
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.08 | 26.21 | 26.05 |
Price/Book Value | 3.78 | 3.83 | 3.12 |
Price/Sales | 2.00 | 5.47 | 3.02 |
Price/Cash Flow | 21.53 | 24.03 | 17.07 |
Price/Earnings
524348
543434
543748
Financial Strength
|
Metric
|
524348
|
543434
|
543748
|
|---|---|---|---|
Quick Ratio | 0.91 | 2.49 | 0.91 |
Current Ratio | 1.66 | 5.17 | 1.94 |
Interest Coverage | 7.41 | 79.53 | 18.28 |
Quick Ratio
524348
543434
543748
Profitability
|
Metric
|
524348
|
543434
|
543748
|
|---|---|---|---|
Return on Assets (Normalized) | — | 13.83% | 9.29% |
Return on Equity (Normalized) | — | 15.76% | 13.33% |
Return on Invested Capital (Normalized) | — | 15.72% | 12.19% |
Return on Assets
524348
543434
543748
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Dcyfkvfmhq | Fzck | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Hjvsrpsb | Sxxdsyl | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Brtnlrbt | Btnqs | $41.4 Bil | |||
| Viatris Inc
VTRS
| Xsdswtl | Mjrlh | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pktpzblpl | Prhyl | $13.7 Bil | |||
| Catalent Inc
CTLT
| Jfcvdmmyn | Nwpvw | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Glzwccsp | Jptj | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kycwjczls | Sqmnnk | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Kdckptqg | Fmv | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Vwxwkmqf | Lhbb | $2.7 Bil |